MSEPX
Price
$20.92
Change
-$0.02 (-0.10%)
Updated
Feb 21 closing price
Net Assets
539.67M
VEMIX
Price
$29.23
Change
+$0.04 (+0.14%)
Updated
Feb 21 closing price
Net Assets
109.55B
Ad is loading...

MSEPX vs VEMIX

Header iconMSEPX vs VEMIX Comparison
Open Charts MSEPX vs VEMIXBanner chart's image
Morgan Stanley Inst Emerging Mkts C
Price$20.92
Change-$0.02 (-0.10%)
VolumeN/A
Net Assets539.67M
Vanguard Emerging Mkts Stock Idx Instl
Price$29.23
Change+$0.04 (+0.14%)
VolumeN/A
Net Assets109.55B
MSEPX vs VEMIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MSEPX vs. VEMIX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSEPX is a StrongBuy and VEMIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEMIX has more cash in the bank: 110B vs. MSEPX (540M). VEMIX pays higher dividends than MSEPX: VEMIX (3.46) vs MSEPX (1.05). MSEPX was incepted earlier than VEMIX: MSEPX (10 years) vs VEMIX (25 years). MSEPX is a more actively managed with annual turnover of: 34.00 vs. VEMIX (5.00). MSEPX has a lower initial minimum investment than VEMIX: MSEPX (1000) vs VEMIX (5000000). VEMIX annual gain was more profitable for investors over the last year : 13.44 vs. MSEPX (9.32). VEMIX return over 5 years is better than : 17.83 vs. MSEPX (-2.24).
MSEPXVEMIXMSEPX / VEMIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years25 years-
Gain YTD4.8054.399109%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets540M110B0%
Annual Yield % from dividends1.053.4630%
Returns for 1 year9.3213.4469%
Returns for 3 years-5.382.02-266%
Returns for 5 years-2.2417.83-13%
Returns for 10 yearsN/A31.51-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SR75.071.13
+1.53%
Spire
LH249.850.68
+0.27%
Laboratory Corp
CAPL22.87-0.38
-1.63%
CrossAmerica Partners LP
EGAN5.09-0.10
-1.93%
eGain Corp
NEUP4.88-0.17
-3.37%
Neuphoria Therapeutics Inc